Diabetes mellitus posterior a casos graves de COVID-19, en Lima, Perú
Resumen
Existe una relación bidireccional entre la COVID-19 y la diabetes mellitus (DM); este última se asocia con un mayor riesgo de COVID-19 grave y se ha observado DM de nueva aparición en pacientes con COVID-19. Se realizó un estudio de cohorte única con análisis exploratorio para evaluar la frecuencia de DM posterior a casos de COVID-19 en Lima, Perú. Se incluyeron pacientes mayores de 18 años, con casos graves de COVID-19 y con glucosa plasmática en ayunas (GPA) dentro de valores normales al ingreso. Se realizaron nuevos controles de glucemia en la fase de recuperación previa al alta médica. En total se incluyeron 55 pacientes y se diagnosticó prediabetes en el 5,53% de ellos; no se registraron casos de DM. Una mayor proporción de vacunados, edad media más baja y menor gravedad de los casos pueden haber contribuido a una menor frecuencia de casos en comparación con otros estudios.
Palabras clave
Texto completo:
PDFReferencias
American Diabetes Association (2020). Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care, 43, 14-31.
Andrew, S., Debra, D., & Mark, C. (2020). COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol, 318, 1084-1090.
Boddu, S., Aurangabadkar, G., & Kuchay, M. (2020). New onset diabetes, type 1 diabetes and COVID-19, Diabetes and Metabolic Syndrome. Clinical Research and Reviews, 14, 2211-2217.
Fadini, G., Morieri, M., Boscari, F., Fioretto, P., Maran, A., & Busetto, L. (2020). Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration. Diabetes Research and Clinical Practice, 168.
Fignani, D., Licata, G., Brusco, N., Nigi, L., Grieco, GE., Marselli, L., Overbergh, L., Gysemans, C., Colli, ML., Marchetti, P., Mathieu, C., Eizirik, DL., Sebastiani, G., & Dotta, F. (2020). SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature. Frontiers in endocrinology, 11. https://doi.org/10.3389/fendo.2020.596898
Herbst, RA., Telford, OT., Hunting, J., Bullock, WM., Manning, E., Hong, BD., D'Alessio, DA., & Setji, TL. (2020). The effects of perioperative dexamethasone on glycemic control and postoperative outcomes. Endocrine practice, 26(2), 218-225. https://doi.org/10.4158/EP-2019-0252
Johns Hopkins Coronavirus Resource Center (2022). COVID-19 Dashboard. Disponible en: https://coronavirus.jhu.edu/map.html (Acceso octubre 2022).
Li, H., Tian, S., Chen, T., Cui, Z., Shi, N., Zhong, X., Qiu, K., Zhang, J., Zeng, T., Chen, L., & Zheng, J. (2020). Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19. Diabetes, obesity & metabolism, 22(10), 1897–1906. https://doi.org/10.1111/dom.14099
Lima-Martínez, M., Carrera Boada, C., Madera-Silva, M. D., Marín, W., & Contreras, M. (2021). COVID-19 and diabetes: A bidirectional relationship. Clínica E Investigación en Arteriosclerosis. 33(3), 151-157.
Liu, F., Long, X., Zhang, B., Zhang, W., Chen, X., & Zhang, Z. (2020). ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection. Clinical Gastroenterology and Hepatology, 18, 2128-2130.
Mathieu, E., Ritchie, H., Ortiz-Ospina, E., Roser, M., Hasell, J., & Appel, C. (2021). A global database of COVID-19 vaccinations. Nature Human Behaviour, 5(7), 947-953.
National Institutes of Health. (2022). Coronavirus Disease 2019 (COVID-19), Treatment Guidelines. Disponible en: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf (Acceso marzo 2022).
Rubino, F., Amiel, S., Zimmet, P., Alberti, G., Bornstein, S., Eckel, R., Mingrone, G., Boehm, B., Cooper, M., Zhonglin, C., Del Prato, S., Linong, J., Hopkins, D., William, H., Khunti, K., Mbanya, JC., & Renard, E. (2020). New-Onset Diabetes in Covid-19. New England Journal of Medicine, 383(8), 789-790.
Sathish, T., & Chandrika, M. (2021). Newly diagnosed diabetes in patients with mild to moderate COVID-19, Diabetes and Metabolic Syndrome. Clinical Research and Reviews, 15, 569-571.
Sathish, T., Kapoor, N., Cao, Y., Tapp, RJ., & Zimmet, P. (2021). Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes Metab, 23.
The Recovery Collaborative Group. (2021). Dexamethasone in Hospitalized Patients with Covid-19. New England Journal of Medicine, 384, 693-704.
Wu, F., Zhao, S., Yu, B., Chen, YM., Wang, W., Song, Z. G., Hu, Y., Tao, Z. W., Tian, JH., Pei, YY., Yuan, ML., Zhang, YL., Dai, FH., Liu, Y., Wang, QM., Zheng, JJ., Xu, L., Holmes, EC., & Zhang, YZ. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265–269. https://doi.org/10.1038/s41586-020-2008-3
Jin-Kui Yang, JK., Jian-Min, J., Liu, S., Bai, P., Wei, H., Wu, F., Xiao-Fang, L., Zhong-Lin, D., & De-Min, H. (2020). New onset COVID-19–related diabetes: an indicator of mortality. medRxiv. https://doi.org/10.1101/2020.04.08.20058040
Zheng, C., Shao, W., Chen, X., Zhang, B., Wang, G., & Zhang, W. (2022). Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. International Journal of Infectious Diseases, 114, 252-260.
Enlaces refback
- No hay ningún enlace refback.
Copyright (c) 2023 Boletín de Malariología y Salud Ambiental